Previous Close | 404.91 |
Open | 404.50 |
Bid | 400.51 x 100 |
Ask | 400.91 x 100 |
Day's Range | 399.29 - 406.83 |
52 Week Range | 316.43 - 448.40 |
Volume | |
Avg. Volume | 1,211,885 |
Market Cap | 103.58B |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | 28.87 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $394.28, indicating a +0.2% shift from the previous trading day.